LIDOCAINE AS A TRANSFORMER AND PRODUCER OF TRANSFORMED COMPLEXES OF DRUGS DELIVERED IN NANO-DOSAGES USING INJECTION IMPLANTS AS PROLONGED RELEASE DEVICES

摘要

The invention relates to a specific method based on suitable quantities of lidocaine for the transformation of drugs approved by the FDA and COFEPRIS, either in liquid or lyopilised form, producing nano-dosages that do not reduce the effectiveness or the therapeutic effects of the drug, converting same into lidocaine-drug complexes. The transformation method, which results in an end product comprising the fusion of molecules of lidocaine with one or more substances comprising drugs, the prior art and the different methods, techniques and instruments result in the formation of intelligent transformed complexes which can be implanted by means of injection close to the specific receptors, characterised by a release that lasts between 8 and 10 days.